Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPHENIDATE Cause Supraventricular tachycardia? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Supraventricular tachycardia have been filed in association with METHYLPHENIDATE (Methylphenidate Hydrochloride). This represents 0.1% of all adverse event reports for METHYLPHENIDATE.

28
Reports of Supraventricular tachycardia with METHYLPHENIDATE
0.1%
of all METHYLPHENIDATE reports
0
Deaths
19
Hospitalizations

How Dangerous Is Supraventricular tachycardia From METHYLPHENIDATE?

Of the 28 reports, 19 (67.9%) required hospitalization.

Is Supraventricular tachycardia Listed in the Official Label?

Yes, Supraventricular tachycardia is listed as a known adverse reaction in the official FDA drug label for METHYLPHENIDATE.

What Other Side Effects Does METHYLPHENIDATE Cause?

Drug ineffective (4,924) Off label use (4,842) No adverse event (4,197) Product quality issue (1,728) Disturbance in attention (1,414) Product substitution issue (1,408) Anxiety (1,356) Drug dose omission (1,330) Headache (1,255) Wrong technique in product usage process (1,250)

What Other Drugs Cause Supraventricular tachycardia?

ADALIMUMAB (141) METOPROLOL (132) ROSIGLITAZONE (114) TREPROSTINIL (113) RITUXIMAB (99) ALBUTEROL (98) IBRUTINIB (96) DEXAMETHASONE (95) ASPIRIN (92) LEVOTHYROXINE (91)

Which METHYLPHENIDATE Alternatives Have Lower Supraventricular tachycardia Risk?

METHYLPHENIDATE vs METHYLPREDNISOLONE METHYLPHENIDATE vs METHYLPREDNISOLONE ACEPONATE METHYLPHENIDATE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPHENIDATE vs METILDIGOXIN METHYLPHENIDATE vs METOCLOPRAMIDE

Related Pages

METHYLPHENIDATE Full Profile All Supraventricular tachycardia Reports All Drugs Causing Supraventricular tachycardia METHYLPHENIDATE Demographics